Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cogent Biosciences, Inc.

7.01
-0.4000-5.40%
Post-market: 6.84-0.1700-2.43%19:58 EST
Volume:972.04K
Turnover:6.91M
Market Cap:798.09M
PE:-3.61
High:7.48
Open:7.45
Low:6.90
Close:7.41
Loading ...
Mar 01, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 25, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Dec 27, 2021

Major Issues Report

8-K - Current report
Oct 05, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Oct 05, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Jul 08, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jun 17, 2021

Major Issues Report

8-K - Current report
May 12, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 12, 2021

Major Issues Report

8-K - Current report